150 Gamma Drive
Thar Pharmaceuticals, Inc. is a clinical-stage, specialty pharmaceutical company that reinvents known, safe, on-the-market drugs by improving their clinical performance and economic benefits. The company focuses on transforming IV drugs into oral drugs for both the drug’s existing and new indications, and is quickly developing a pipeline of drug candidates using its proprietary technology platform.
CEO: Raymond K. Houck
CMO: Ira Kalfus, MD
CSO: Mazen Hanna, PhD
Please click here for clinical trial information.